Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin

Cornea

Volumn 28, Issue 1, 2009, Pages 46-50

  Karalezli, Aylin ^a   Borazan, Mehmet ^a   Altinors, Dilek D ^a   Dursun, Recep ^a   Kiyici, Halil ^a   Akova, Yonca A ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Dry eye; Impression cytology; Isotretinoin; Tear film stability

Indexed keywords

ISOTRETINOIN; DERMATOLOGICAL AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; BLEPHARITIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVA EPITHELIUM; EPITHELIUM CELL; EYELID DISEASE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HYPEREMIA; IMPRESSION CYTOLOGY; LACRIMATION; MALE; MEIBOMIANITIS; OPHTHALMOSCOPY; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIRMER TEST; SEBACEOUS GLAND DISEASE; SYSTEMIC THERAPY; TEAR FILM; CHEMICALLY INDUCED DISORDER; CONJUNCTIVA; DRUG EFFECT; EYE; EYE DISEASE; INCIDENCE; LACRIMAL FLUID; ORAL DRUG ADMINISTRATION; PATHOLOGY; SECRETION;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLEPHARITIS; CONJUNCTIVA; DERMATOLOGIC AGENTS; EPITHELIAL CELLS; EYE; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISOTRETINOIN; MALE; TEARS; YOUNG ADULT;

EID: 62149087892     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318183a396     Document Type: Article

References (32)

1. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132:299-305.
2. Mills CM, Marks R. Adverse reactions to oral retinoids. An update. Drug Saf. 1993;9:280-290.
3. Coleman R, MacDonald D. Effects of isotretinoin on male reproductive system. Lancet. 1994;344:198.
4. Bigby M, Stern RS. Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol. 1988; 18:543-552.
5. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol. 1994;131:360-363.
6. Fraunfelder FT, LaBraico JM, Meyer SM. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol. 1985;100:534-537.
7. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
8. Irkec MT, and Turkish OSDI Study Group. Reliability and validity of Turkish translation of the Ocular Surface Disease Index (OSDI) in dry eye syndrome. Invest Ophthalmol Vis Sci. 2007;48:E-Abstract 408.
9. Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
10. Egbert PR, Lauber S, Maurice DM. A simple conjunctival biopsy. Am J Ophthalmol. 1977;84:798-801.
11. Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol. 1984;102:1049-1051.
12. King K, Jones DH, Daltrey DC, et al. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107:583-590.
13. Stewart ME, Benoit AM, Downing DT, et al. Suppression of sebum secretion with 13-cis-retinoic acid: effect on individual skin surface lipids and implications for their anatomic origin. J Invest Dermatol. 1984;82:74-78.
14. Dalziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol. 1987;117:317-323.
15. Ensink BW, van Voorst Vader PC. Ophthalmological side-effects of 13-cis-retinoid therapy. Br J Dermatol. 1983;108:627.
16. Jester JV, Rife L, Nii D, et al. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1982;22:660-667.
17. Lambert RW, Smith RE. Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model. Invest Ophthalmol Vis Sci. 1988;29:1559-1564.
18. Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy. Cornea. 1991;10:286-290.
19. Milson J, Jones DH, King K, et al. Ophthalmological effects of 13-cis-retinoic acid therapy for acne vulgaris. Br J Dermatol. 1982;107:491.
20. Patel SJ, Lundy DC. Ocular manifestations of autoimmune disease. Am Fam Physician. 2002;66:991-998.
21. Bozkurt B, Irkexc MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol. 2002;12:173-176.
22. Egger SF, Huber-Spitzy V, Böhler K, et al. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora. Acta Ophthalmol Scand. 1995;73:355-357.
23. O'day K. Bengal rose as an aid in the diagnosis of kerato-conjunctivitis sicca (Sjögren's syndrome). Med J Aust. 1951;2:708-709.
24. Wilson FM 2nd. Rose bengal staining of epibulbar squamous neoplasms. Ophthalmic Surg. 1976;721-23.
25. Marsh RJ, Fraunfelder FT, McGill JI. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976;94:1899-1902.
26. Tseng SC, Hirst LW, Maumenee AE, et al. Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology. 1984;91: 545-552.
27. Dursun D, Ertan A, Bilezikci B, et al. Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion. Curr Eye Res. 2003;26:263-269.
28. Kinoshita S, Kiorpes TC, Friend J, et al. Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch Ophthalmol. 1983;101:1284-1287.
29. Paridaens AD, McCartney AC, Curling OM, et al. Impression cytology of conjunctival melanosis and melanoma. Br J Ophthalmol. 1992;76: 198-201.
30. Nelson JD, Havener VR, Cameron JD. Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol. 1983;101: 1869-1872.
31. Rismondo V, Ubels JL. Isotretinoin in lacrimal gland fluid and tears. Arch Ophthalmol. 1987;105:416-420.
32. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007;15: 389-393.